The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
Clinical trial NCT02282059 · COMPLETED
Trial details
- NCT number
- NCT02282059
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-12
- Primary completion
- 2022-12-12
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.